Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
Conditions
Non Muscle Invasive Bladder Cancer · High-grade Ta/ T1 Papillary Disease Bladder Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking University First Hospital (First Clinical Medical School of Peking University), Beijing, Beijing Municipality, China
Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Hunan Cancer Hospital, Changsha, Hunan, China
The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
The First Hospital of China Medical University, Shenyang, Liaoning, China
Qilu Hospital of Shandong University, Jinan, Shandong, China
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
West China Hospital, Sichuan University, Chengdu, Sichuan, China
The Second Hospital of Tianjin Medical University, Tianjin, Tianjin Municipality, China
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Study leads
Dinɡwei Ye, M.D.
Principal Investigator
Fudan University